Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases

Background and aims: Brazilian patients with inflammatory bowel diseases (IBD) requiring therapy with biological agents usually have access to medicines through the National Unified Health Care System (SUS). This study aimed to analyze Brazilian IBD patient perception regarding access (availability...

Descripción completa

Detalles Bibliográficos
Autores principales: Parra, Rogerio Serafim, da Costa Ferreira, Sandro, Machado, Vanessa Foresto, Nigro, Cintia Maura Caseiro, da Rocha, José Joaquim Ribeiro, de Almeida Troncon, Luiz Ernesto, Feres, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095198/
https://www.ncbi.nlm.nih.gov/pubmed/37048755
http://dx.doi.org/10.3390/jcm12072672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095198/
https://www.ncbi.nlm.nih.gov/pubmed/37048755
http://dx.doi.org/10.3390/jcm12072672

Ejemplares similares